NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 45 filers reported holding NEXTCURE INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $57,000 | -89.9% | 7,111 | -87.4% | 0.00% | – |
Q1 2021 | $565,000 | -16.7% | 56,393 | -9.5% | 0.00% | – |
Q4 2020 | $678,000 | -86.0% | 62,305 | -88.7% | 0.00% | -100.0% |
Q3 2020 | $4,848,000 | +2670.3% | 550,907 | +6646.4% | 0.00% | – |
Q2 2020 | $175,000 | -8.4% | 8,166 | +58.7% | 0.00% | – |
Q1 2020 | $191,000 | -34.1% | 5,144 | -0.6% | 0.00% | – |
Q4 2019 | $290,000 | +1060.0% | 5,173 | +507.2% | 0.00% | – |
Q3 2019 | $25,000 | -21.9% | 852 | -60.9% | 0.00% | – |
Q2 2019 | $32,000 | – | 2,179 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners X LLC | 1,676,884 | $18,278,000 | 19.00% |
SILVERARC CAPITAL MANAGEMENT, LLC | 130,000 | $1,417,000 | 0.82% |
Lion Point Capital, LP | 300,000 | $3,270,000 | 0.63% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 34,285 | $374,000 | 0.59% |
Orbimed Advisors | 2,711,013 | $29,550,000 | 0.26% |
DAFNA Capital Management LLC | 65,000 | $709,000 | 0.21% |
Virtus ETF Advisers LLC | 23,985 | $261,000 | 0.11% |
OCCUDO QUANTITATIVE STRATEGIES LP | 31,357 | $342,000 | 0.11% |
Krensavage Asset Management, LLC | 30,292 | $330,000 | 0.10% |
Ikarian Capital, LLC | 200,000 | $2,179,000 | 0.10% |